Cleared Traditional

SQ.line KERRISON (K223596) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223596 · Aesculap, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2023
Decision
209d
Days
Class 2
Risk

K223596 is an FDA 510(k) clearance for the SQ.line KERRISON. Classified as Rongeur, Manual (product code HAE), Class II - Special Controls.

Submitted by Aesculap, Inc. (Center Valley, US). The FDA issued a Cleared decision on June 29, 2023 after a review of 209 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4840 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Aesculap, Inc. devices

Submission Details

510(k) Number K223596 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2022
Decision Date June 29, 2023
Days to Decision 209 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d slower than avg
Panel avg: 148d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HAE Rongeur, Manual
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAE Rongeur, Manual

All 35
Devices cleared under the same product code (HAE) and FDA review panel - the closest regulatory comparables to K223596.
Geister K-Rex rongeurs
K242759 · Geister Medizin Technik GmbH · Jun 2025
Rebellion, Phantom Multi-Bite Kerrison Rongeur
K230256 · Morpheus AG · Mar 2023
Rebellion
K221818 · Morpheus AG · Oct 2022
KLS Martin Neuro Rongeurs
K210741 · KLS-Martin L.P. · Jun 2022
Rebellion, Phantom Multi-Bite Kerrison Rongeur 
K200768 · Morpheus AG · May 2021
Wiggins Medical Surgical Instruments
K200383 · Wiggins Medical · Jul 2020